Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (741-750 of 869) with videos related to

Pageof 87
Sort By:
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Ebiomedicine|January 25, 2021
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trialsYunda Huang, Logashvari Naidoo, Lily Zhang, et al.
Science Translational Medicine|November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
Plos One|September 2, 2016
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African ParticipantsGavin Churchyard, Koleka Mlisana, Shelly Karuna, et al.
Cell Host & Microbe|September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV ChallengeAmarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
JAMA|August 15, 2006
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi StudyIbou Thior, Shahin Lockman, Laura M Smeaton, et al.
Scientific Reports|February 9, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine RegimensXiaoying Shen, Fatima Laher, Zoe Moodie, et al.
Microbiology Resource Announcements|January 4, 2023
Genome Sequence of Gordonia rubripertincta Phage Survivors, a Cluster CT SiphovirusAmber M Amend, Jacob P Bifone, Justin C Brewer, et al.
Nature Communications|July 7, 2022
Mutations in DNA polymerase δ subunit 1 co-segregate with CMD2-type resistance to Cassava Mosaic GeminivirusesYi-Wen Lim, Ben N Mansfeld, Pascal Schläpfer, et al.
Journal of Virology|January 16, 2025
Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistancePaula Cohen, Bronwen E Lambson, Nonhlanhla N Mkhize, et al.
Pageof 87

Showing results (741-750 of 869) with videos related to

Sort By:
Pageof 87
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Ebiomedicine|January 25, 2021
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trialsYunda Huang, Logashvari Naidoo, Lily Zhang, et al.
Science Translational Medicine|November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
Plos One|September 2, 2016
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African ParticipantsGavin Churchyard, Koleka Mlisana, Shelly Karuna, et al.
Cell Host & Microbe|September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV ChallengeAmarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
JAMA|August 15, 2006
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi StudyIbou Thior, Shahin Lockman, Laura M Smeaton, et al.
Scientific Reports|February 9, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine RegimensXiaoying Shen, Fatima Laher, Zoe Moodie, et al.
Microbiology Resource Announcements|January 4, 2023
Genome Sequence of Gordonia rubripertincta Phage Survivors, a Cluster CT SiphovirusAmber M Amend, Jacob P Bifone, Justin C Brewer, et al.
Nature Communications|July 7, 2022
Mutations in DNA polymerase δ subunit 1 co-segregate with CMD2-type resistance to Cassava Mosaic GeminivirusesYi-Wen Lim, Ben N Mansfeld, Pascal Schläpfer, et al.
Journal of Virology|January 16, 2025
Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistancePaula Cohen, Bronwen E Lambson, Nonhlanhla N Mkhize, et al.
Pageof 87